A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy

BACKGROUND: Adoptive transfer of genetically engineered T-cells to express antigen-specific T-cell receptor (TCR) is a feasible and effective therapeutic approach for numerous types of cancers, including Epstein–Barr virus (EBV)-associated malignancies. Here, we describe a TCR gene transfer regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hyun-Il, Kim, Un-Hee, Shin, A-Ri, Won, Ji-Na, Lee, Hyun-Joo, Sohn, Hyun-Jung, Kim, Tai-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830600/
https://www.ncbi.nlm.nih.gov/pubmed/29360818
http://dx.doi.org/10.1038/bjc.2017.475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830600/
https://www.ncbi.nlm.nih.gov/pubmed/29360818
http://dx.doi.org/10.1038/bjc.2017.475

Ejemplares similares